AKT1 and breast cancer: [38] reported that glaucocalyxin A induced apoptosis and G2/M cell cycle arrest of BC cells by inhibiting the PI3K-AKT signaling pathway, indicating that targeting PI3K-AKT signaling may be a potential therapeutic method for BC.